Search Results - "Braghini, M.R."

Telomere length exhibits a strong association with non-alcoholic fatty liver disease progression in children by Braghini, M.R., Bianco, S.D., Bianchi, M., Mosca, A., Veraldi, S., Francalanci, P., Mazza, T., Alisi, A.

Get full text

Copper chelation as a new treatment strategy to counteract hepatocellular carcinoma by Santini, S.J., Braghini, M.R., Alisi, A., Balsano, C.

Get full text

Intestinal activation of the lxr-α receptor protects the liver from NASH-related damage by Lioci, G., Gurrado, F., Panera, N., Braghini, M.R., De Stefanis, C., Alisi, A., Svegliati-Baroni, G.

“…Non-Alcoholic fatty liver disease (NAFLD) is the most common liver disorder in western countries, with an estimated global prevalence of 25%, with differences…”
Get full text

Growth differentiation factor 15 performance as a novel non-invasive circulating biomarker of liver damage in paediatric non-alcoholic fatty liver disease by Mosca, A., Braghini, M.R., Andolina, G., Comparcola, D., Alterio, A., Sartorelli, M.R., Monti, L., Maggiore, G., Alisi, A., Panera, N.

Get full text

OC-02Activation of Liver X Receptor-α in the gut protects against liver injury in nonalcoholic steatohepatitis (NASH) by Gurrado, F., Lioci, G., Panera, N., Braghini, M.R., De Stefanis, C., Cucco, M., Alisi, A., Svegliati-Baroni, G.

Get full text

Hydroxytyrosol and vitamin E combination therapy exerts beneficial effects on NAFLD-related fibrosis by Panera, N., Braghini, M.R., Crudele, A., Bianchi, M., Conti, L.A., Mosca, A., Comparcola, D., Sartorelli, M.R., Smeriglio, A., Trombetta, D., Alisi, A.

Get full text